Bell Asset Management LTD Amgen Inc Transaction History

Bell Asset Management LTD

$536 Million
Q4 2024

A detailed history of Bell Asset Management LTD transactions in Amgen Inc stock. As of the latest transaction made, Bell Asset Management LTD holds 18,743 shares of AMGN stock, worth $5.68 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

18,743

Previous 7,733 142.38%

Holding current value

$5.68 Million

Previous $2.49 Million 96.11%

% of portfolio

0.91%

Previous 0.46%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$258.78 - $328.31 $2.85 Million - $3.61 Million	11,010 Added 142.38%	18,743 $4.89 Million
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $2.79 Million - $3.05 Million	-9,029 Reduced 53.87%	7,733 $2.49 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $31,267 - $37,997	-119 Reduced 0.7%	16,762 $5.24 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $913,889 - $1.1 Million	-3,399 Reduced 16.76%	16,881 $4.8 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $2.41 Million - $2.72 Million	-9,435 Reduced 31.75%	20,280 $5.84 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $3.52 Million - $4.36 Million	-16,077 Reduced 35.11%	29,715 $7.99 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $17,784 - $21,029	-83 Reduced 0.18%	45,792 $10.2 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $4.77 Million - $5.81 Million	21,126 Added 85.36%	45,875 $11.1 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $1.88 Million - $2.39 Million	-8,212 Reduced 24.91%	24,749 $6.5 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $107,965 - $121,765	-481 Reduced 1.44%	32,961 $7.43 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $3.21 Million - $3.57 Million	-13,900 Reduced 29.36%	33,442 $8.14 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $52,186 - $57,731	-238 Reduced 0.5%	47,342 $11.4 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $71,000 - $81,253	357 Added 0.76%	47,580 $10.7 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $4.61 Million - $5.4 Million	21,709 Added 85.09%	47,223 $10 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $20,321 - $22,545	-87 Reduced 0.34%	25,514 $6.22 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $376,359 - $438,585	-1,696 Reduced 6.21%	25,601 $6.37 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $280,861 - $334,455	1,298 Added 4.99%	27,297 $6.28 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $598,826 - $665,944	2,552 Added 10.88%	25,999 $6.61 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $1.73 Million - $2.12 Million	8,732 Added 59.34%	23,447 $5.53 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $107,521 - $142,603	590 Added 4.18%	14,715 $2.98 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $3.02 Million - $3.88 Million	-15,941 Reduced 53.02%	14,125 $3.41 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $596,152 - $714,314	-3,424 Reduced 10.22%	30,066 $5.82 Million
Q1 2019 Apr 11, 2019	BUY	$180.87 - $203.88 $256,292 - $288,897	1,417 Added 4.42%	33,490 $6.36 Million
Q4 2018 Jan 22, 2019	SELL	$178.4 - $208.25 $14,807 - $17,284	-83 Reduced 0.26%	32,073 $6.24 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $302,763 - $341,326	-1,634 Reduced 4.84%	32,156 $6.67 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $41,844 - $47,000	252 Added 0.75%	33,790 $6.25 Million
Q1 2018 Apr 30, 2018	BUY	$169.43 - $198.0 $11,351 - $13,266	67 Added 0.2%	33,538 $7.45 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $5.65 Million - $6.31 Million	33,471	33,471 $5.82 Million

Others Institutions Holding AMGN

# of Institutions

3,164

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $162B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bell Asset Management LTD with notifications on news.

Account

Bell Asset Management LTD Amgen Inc Transaction History